Gene · 442909
Papers1,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RETRACTION: MicroRNA-342 Promotes the Malignant-Like Phenotype of Endometrial Stromal Cells via Regulation of Annexin A2. | Anal Cell Pathol (Amst) | 2026 | 42781897 | PubTator, text mining | PubMed |
| Metastasis of triple negative breast cancer is regulated by a targetable miR-342-E2F network. | EMBO Mol Med | 2026 | 42629473 | PubTator, text mining | PubMed |
Consolidating Clinical Insights and Uncovering Novel Regulatory Mechanisms of Exosomal MicroRNAs in Obesity and Metabolic Dysfunction Associated Steatotic Liver Disease: A Systematic Review and Bioinformatics Analysis. | Food Sci Nutr | 2026 | 42254426 | PubTator, text mining | PubMed |
| Exosomes in diabetic kidney disease: pathogenesis, biomarker discovery, and emerging therapeutics-a comprehensive systematic review. | Ren Fail | 2026 | 41845912 | PubTator, text mining | PubMed |
| Diagnostic Potential of Circulating miRNAs in Glioma: A Systematic Review and Meta-Analysis. | Int J Mol Sci | 2026 | 41751817 | PubTator, text mining | PubMed |
| Diet-Driven Epigenetic Alterations in Colorectal Cancer: From DNA Methylation and microRNA Expression to Liquid Biopsy Readouts. | Biomedicines | 2026 | 41751166 | PubTator, text mining | PubMed |
| The relationship between serum levels of miR-342 and miR-148a and acute lung injury in sepsis patients. | Open Med (Wars) | 2026 | 41726132 | PubTator, text mining | PubMed |
| miRNA gene mutations commonly disrupt the proper functioning of miRNA genes. | Sci Adv | 2026 | 41706844 | PubTator, text mining | PubMed |
| The Expression and Potential Role of MicroRNAs in Oral Lichen Planus. | J Oral Pathol Med | 2026 | 41635022 | PubTator, text mining | PubMed |
| Role of tumor‑infiltrating lymphocytes and miR‑155 in breast cancer: Insights into carcinogenesis and their potential as prognostic biomarkers (Review). | Oncol Rep | 2026 | 41543151 | PubTator, text mining | PubMed |
| A New Radiotranscriptomic Approach to Analyze Combined Sets of T3b Stage-Specific Genes and Radiomic Features in Prostate Cancer. | Cancer Rep (Hoboken) | 2025 | 41386760 | PubTator, text mining | PubMed |
| miRNA expression haplotype in Hispanics with endometriosis. | Front Reprod Health | 2025 | 41078970 | PubTator, text mining | PubMed |
| MicroRNAs and Cancer Racial Disparities. | Wiley Interdiscip Rev RNA | 2025 | 40998459 | PubTator, text mining | PubMed |
| Navigating the Landscape of Exosomal microRNAs: Charting Their Pivotal Role as Biomarkers in Hematological Malignancies. | Noncoding RNA | 2025 | 40981381 | PubTator, text mining | PubMed |
| The use of circulating miRNAs for the diagnosis, prognosis, and personalized treatment of MASLD. | J Physiol Biochem | 2025 | 40668532 | PubTator, text mining | PubMed |
| Machine learning-based stratification of prediabetes and type 2 diabetes progression. | Diabetol Metab Syndr | 2025 | 40533788 | PubTator, text mining | PubMed |
| Reprogramming liver metastasis-associated macrophages toward an anti-tumoral phenotype through enforced miR-342 expression. | Cell Rep | 2025 | 40253698 | PubTator, text mining | PubMed |
| Peripheral Blood miRNA Expression in Patients with Essential Hypertension in the Han Chinese Population in Hefei, China. | Biochem Genet | 2025 | 38907084 | PubTator, text mining | PubMed |
| Microrna-342 inhibits hepatocellular carcinoma cell proliferation and promotes apoptosis through the FOXP1/MYCBP Signaling Axis. | Toxicol Res (Camb) | 2024 | 39698396 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Biomarkers of Pregnancy Complications. | Int J Mol Sci | 2024 | 39596014 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/442909/papers